30 Their overall consensus was that IBD patients showed a trend toward higher risks of developing hematological malignancies, more specifically leukemia in UC and lymphoma in CD based on large population-based cohort studies.
← all excerpts
Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy.
1
—
—